SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer

NCT00026260 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: semaxanib

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]